Corneal light scattering after CXL gives distinctive spatial and temporal profiles

Article

The spatial distribution and temporal profiles of corneal light scattering after corneal collagen crosslinking (CXL) are distinctive in keratoconus patients.

The spatial distribution and temporal profiles of corneal light scattering after corneal collagen crosslinking (CXL) are distinctive in keratoconus patients, states a study published by the Journal of Cataract and Refractive Surgery.

A team led by Dr Anders Behndig, Department of Clinical Sciences and Ophthalmology, Umeå University, Sweden, included 11 eyes in a case series of 11 keratoconus patients. All eyes were examined with Scheimpflug photography pre-CXL and 1 and 5 months post-CXL. Corneal light scattering was recorded throughout corneal thickness at 8 measurement points 0.0 to 3.0mm from the central cornea.

After CXL, central corneal light scattering increased significantly after 1 month. Corneal light scattering decreased after 6 months but stayed higher than pre-CXL values.

Light scattering at 1 month was more defined in the superficial stroma and gradually reduced to zero at 240μm depth. It was found that corneal light scattering was greater at the corneal centre. The second peak of light scattering occurred 6 months postoperatively between 240μm and 340μm depth.It was also concluded that Scheimpflug photography is useful for corneal light scattering.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.